Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates

Go back to Viridian Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Updates
(NASDAQ: VRDN) Delayed: 23.17 --0 (-0%)
Previous Close $23.17    52 Week High
Open $23.17    52 Week Low
Day High $23.17    P/E N/A 
Day Low $23.17    EPS
Volume 132